(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MYPHARMACYPLUS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MYPHARMACYPLUS

ST13

US500000076307804

Class

36

Filing

76307804

Registration

2955263

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

09/23/2025

Trademark type

Word

Nice classes

36

Filing date

08/31/2001

Registration date

05/24/2005

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/02/2025

Last transaction

09/23/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/30/2002

First use in commerce

11/30/2002

Drawing code

1

Owner type

03

Owner location

Mountlake Terrace, WA

Examiner

CAPSHAW, DANIEL

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

P. C. (pessoa física)
P. C. (pessoa física)

Representatives

Jerald E. Nagae, Reg. No. 29, 418 CHRISTENSEN O'CONNOR JOHNSON KINDNESS

Technical classification

Nice Classes

Class 36

Vienna Codes

No Vienna codes available.

Goods and services

Class 36

pharmaceutical and prescription drug insurance underwriting; administration and organizing of prepaid pharmaceutical and prescription drug plansincluding claims administration for pharmaceutical and prescription drug benefits

Publications

History of USPTO decisions and trademark events.

35 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/02/2025

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

09/02/2025

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/02/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/02/2025

E89R

TEAS SECTION 8 & 9 RECEIVED

04/28/2025

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/24/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/14/2019

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/14/2019

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/16/2014

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/16/2014

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/16/2014

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

09/16/2014

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

06/28/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/24/2014

E89R

TEAS SECTION 8 & 9 RECEIVED

06/06/2014

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/05/2014

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/29/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

05/03/2011

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/03/2011

E815

TEAS SECTION 8 & 15 RECEIVED

04/15/2011

R.PR

REGISTERED-PRINCIPAL REGISTER

05/24/2005

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

02/24/2005

ALIE

ASSIGNED TO LIE

02/18/2005

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

02/11/2005

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/25/2005

IUAF

USE AMENDMENT FILED

01/25/2005

EISU

TEAS STATEMENT OF USE RECEIVED

01/25/2005

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

07/27/2004

PUBO

PUBLISHED FOR OPPOSITION

05/04/2004

NPUB

NOTICE OF PUBLICATION

04/14/2004

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/24/2004

CFIT

CASE FILE IN TICRS

01/22/2004

CNSL

LETTER OF SUSPENSION MAILED

01/11/2002

DOCK

ASSIGNED TO EXAMINER

10/31/2001

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/01/2001

Continuous trademark protection

Get notified about every new filing that threatens MYPHARMACYPLUS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.